Search

everythinglearnresearchcommunity

for

Search:↓

Classical PCOS types A and B are most common and linked to higher health risks.

Removing one ovary helped treat a woman's severe PCOS symptoms when medicine didn't work.

The document concludes that managing Dunnigan-Type Familial Partial Lipodystrophy involves treating associated health issues and using medications like metformin and leptin replacement.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Ovarian Hyperthecosis caused hypersexuality in an older woman and was successfully treated with surgery.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

PCOS is linked to low-grade chronic inflammation.

The document suggests new ways to assess and diagnose hyperandrogenism to improve accuracy.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.

The conclusion is that PCOS is a common cause of hirsutism in young obese women, and early treatment is important to reduce the risk of metabolic syndrome.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

Follicular unit grafting is a procedure used to treat hair loss, where small hair grafts are placed into the scalp, with future treatments likely to involve smaller incisions and cell-based therapies.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Certain extracts from Curcuma aeruginosa Roxb. and germacrone can boost the skin's absorption of minoxidil, a hair growth promoter, making it more effective.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

The meeting presented new findings on hair stem cells, pigmentation, genetics, and modern hair treatment techniques.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

PRP and cell therapies may help with hair loss, but more research is needed.

Umbilical cord-derived media is safe and effective for hair growth.

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Finasteride helps hair growth by decreasing cell death in hair follicles.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.